Jane Street Group, LLC Veracyte, Inc. Transaction History

Jane Street Group, LLC

$444 Billion
Q4 2024

A detailed history of Jane Street Group, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 103,210 shares of VCYT stock, worth $4.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,210

Previous 301,652 65.79%

Holding current value

$4.24 Million

Previous $10.3 Million 60.19%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$31.92 - $44.4 $6.33 Million - $8.81 Million	-198,442 Reduced 65.79%	103,210 $4.09 Million
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $4.65 Million - $7.81 Million	221,504 Added 276.37%	301,652 $10.3 Million
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $723,130 - $902,954	38,342 Added 91.71%	80,148 $1.74 Million
Q1 2024 May 15, 2024	SELL	$21.0 - $29.1 $1.16 Million - $1.61 Million	-55,186 Reduced 56.9%	41,806 $926,000
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $960,245 - $1.4 Million	48,694 Added 100.82%	96,992 $2.67 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $1.81 Million - $2.42 Million	-80,870 Reduced 62.61%	48,298 $1.08 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $1.98 Million - $2.55 Million	94,615 Added 273.83%	129,168 $3.29 Million
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $676,670 - $917,023	-32,880 Reduced 48.76%	34,553 $770,000
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $1.03 Million - $2.02 Million	67,433 New	67,433 $1.6 Million
Q2 2022 Aug 16, 2022	BUY	$15.45 - $29.52 $131,433 - $251,126	8,507 Added 63.68%	21,866 $435,000
Q4 2021 Feb 15, 2022	BUY	$36.09 - $53.79 $253,063 - $377,175	7,012 Added 110.48%	13,359 $550,000
Q3 2021 Nov 16, 2021	SELL	$35.62 - $52.97 $112,701 - $167,597	-3,164 Reduced 33.27%	6,347 $295,000
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $133,736 - $229,877	-4,060 Reduced 29.92%	9,511 $380,000
Q1 2021 May 18, 2021	SELL	$44.47 - $81.38 $1.64 Million - $3 Million	-36,821 Reduced 73.07%	13,571 $729,000
Q4 2020 Feb 17, 2021	BUY	$32.49 - $61.88 $1.15 Million - $2.2 Million	35,490 Added 238.16%	50,392 $2.47 Million
Q3 2020 Nov 17, 2020	BUY	$26.73 - $35.67 $183,020 - $244,232	6,847 Added 85.0%	14,902 $484,000
Q2 2020 Aug 17, 2020	BUY	$19.49 - $28.11 $156,991 - $226,426	8,055 New	8,055 $209,000
Q1 2019 May 16, 2019	SELL	$12.0 - $25.76 $468,504 - $1.01 Million	-39,042 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$9.15 - $14.85 $357,234 - $579,773	39,042 New	39,042 $491,000

Others Institutions Holding VCYT

# of Institutions

336

Shares Held

81.1M

Call Options Held

202K

Put Options Held

18.6K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.94B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Veracyte, Inc. Transaction History